Highland Capital Management, LLC Royalty Pharma PLC Transaction History

Highland Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	SELL	$37.53 - $44.22 $1.96 Million - $2.3 Million	-52,094 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$37.46 - $42.44 $25,809 - $29,241	689 Added 1.34%	52,094 $2.03 Million
Q4 2021 Jan 28, 2022	SELL	$35.17 - $42.48 $191,641 - $231,473	-5,449 Reduced 9.58%	51,405 $2.05 Million
Q3 2021 Oct 25, 2021	BUY	$36.14 - $42.24 $2.05 Million - $2.4 Million	56,854 New	56,854 $2.06 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highland Capital Management, LLC with notifications on news.